Your browser doesn't support javascript.
loading
When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities.
Sundahl, Nora; Gillessen, Silke; Sweeney, Christopher; Ost, Piet.
Afiliação
  • Sundahl N; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK. Electronic address: nora.sundahl@ugent.be.
  • Gillessen S; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK.
  • Sweeney C; Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Ost P; Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
Eur Urol ; 79(5): 565-567, 2021 05.
Article em En | MEDLINE | ID: mdl-32847699
ABSTRACT
Even though prostate-specific membrane antigen (PSMA)-positron emission tomography (PET)-computed tomography (CT) is more accurate than conventional imaging in prostate cancer patients, its impact on patient-relevant outcomes is unknown. We argue that more evidence is required before using PSMA-PET-CT as the standard of care for staging.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Idioma: En Ano de publicação: 2021 Tipo de documento: Article